Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
Clinical trial NCT03405402 · COMPLETED
Trial details
- NCT number
- NCT03405402
- Sponsor
- Hanane EL KENZ
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-13
- Primary completion
- 2020-08-03
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.